b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="jhemonc" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2739531/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinoma</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739531/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="Journal of Hematology &amp; Oncology" /><meta name="citation_title" content="Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinoma" /><meta name="citation_authors" content="Yeng Chen, Boon-Kiong Lim, Onn H Hashim" /><meta name="citation_date" content="2009" /><meta name="citation_volume" content="2" /><meta name="citation_firstpage" content="37" /><meta name="citation_doi" content="10.1186/1756-8722-2-37" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2739531/?report=abstract" /><meta name="citation_pmid" content="19709441" /><meta name="DC.Title" content="Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinoma" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="BioMed Central" /><meta name="DC.Contributor" content="Yeng Chen" /><meta name="DC.Contributor" content="Boon-Kiong Lim" /><meta name="DC.Contributor" content="Onn H Hashim" /><meta name="DC.Date" content="2009" /><meta name="DC.Identifier" content="10.1186/1756-8722-2-37" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinoma" /><meta property="og:type" content="article" /><meta property="og:description" content="The general enhanced expression of \xce\xb1[1] -antichymotrypsin (ACT), clusterin (CLU), \xce\xb1[1] -antitrypsin (AAT), haptoglobin \xce\xb2-chain (HAP), and leucine rich glycoprotein (LRG) in the sera of patients with epithelial ovarian carcinoma ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2739531/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-jhemonc.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2739531/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2739531/pdf/1756-8722-2-37.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B16BAE9A2F1A10000000009090909.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/617/">J Hematol Oncol</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/176182/">v.2; 2009</a></li><li class="accid">PMC2739531</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-jhemonc.png" alt="Logo of jhemonc" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area alt="Link to Publisher\'s site" title="Link to Publisher\'s site" shape="default" coords="0,0,499,74" href="https://jhoonline.biomedcentral.com/" target="pmc_ext" ref="reftype=publisher&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">J Hematol Oncol</span>. 2009; 2: 37. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Aug 27. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1756-8722-2-37" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1756-8722-2-37</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2739531</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19709441">19709441</a></div></div></div></div><h1 class="content-title">Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinoma</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Chen%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19709441" id="A1" class="affpopup" co-rid="_co_idm139878654288240" co-class="co-affbox">Yeng Chen</a>,<sup>1,</sup><sup>2</sup> <a href="/pubmed/?term=Lim%20BK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19709441" id="A2" class="affpopup" co-rid="_co_idm139878654287488" co-class="co-affbox">Boon-Kiong Lim</a>,<sup>3,</sup><sup>4</sup> and  <a href="/pubmed/?term=Hashim%20OH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19709441" id="A3" class="affpopup" co-rid="_co_idm139878721665472" co-class="co-affbox">Onn H Hashim</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup>1,</sup><sup>4</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm139878654288240"><h3 class="no_margin">Yeng Chen</h3><p><sup>1</sup>Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia</p><p><sup>2</sup>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia</p><div>Find articles by <a href="/pubmed/?term=Chen%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19709441">Yeng Chen</a></div></div><div id="_co_idm139878654287488"><h3 class="no_margin">Boon-Kiong Lim</h3><p><sup>3</sup>Department of Obstetrics &#x00026; Gynecology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia</p><p><sup>4</sup>University of Malaya Centre for Proteomics Research (UMCPR), University of Malaya, 50603 Kuala Lumpur, Malaysia</p><div>Find articles by <a href="/pubmed/?term=Lim%20BK%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19709441">Boon-Kiong Lim</a></div></div><div id="_co_idm139878721665472"><h3 class="no_margin">Onn H Hashim</h3><p><sup>1</sup>Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia</p><p><sup>4</sup>University of Malaya Centre for Proteomics Research (UMCPR), University of Malaya, 50603 Kuala Lumpur, Malaysia</p><div>Find articles by <a href="/pubmed/?term=Hashim%20OH%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19709441">Onn H Hashim</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm139878651620272_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm139878651620272_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm139878651620272_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm139878651620272_ai" style="display:none"><div class="fm-affl" lang="en" id="I1"><sup>1</sup>Department of Molecular Medicine, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia</div><div class="fm-affl" lang="en" id="I2"><sup>2</sup>Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 Minden, Penang, Malaysia</div><div class="fm-affl" lang="en" id="I3"><sup>3</sup>Department of Obstetrics &#x00026; Gynecology, Faculty of Medicine, University of Malaya, 50603 Kuala Lumpur, Malaysia</div><div class="fm-affl" lang="en" id="I4"><sup>4</sup>University of Malaya Centre for Proteomics Research (UMCPR), University of Malaya, 50603 Kuala Lumpur, Malaysia</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div><div><span class="contrib-email" id="A1">Yeng Chen: <a href="mailto:dev@null" data-email="moc.liamtoh@gneynehc" class="oemail">moc.liamtoh@gneynehc</a>; </span> <span class="contrib-email" id="A2">Boon-Kiong Lim: <a href="mailto:dev@null" data-email="ym.ude.cmmu@kbmil" class="oemail">ym.ude.cmmu@kbmil</a>; </span> <span class="contrib-email" id="A3">Onn H Hashim: <a href="mailto:dev@null" data-email="ym.ude.mu@mihsahnno" class="oemail">ym.ude.mu@mihsahnno</a></span> </div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm139878651620272_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Jun 22; Accepted 2009 Aug 27.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm139878651620272_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a>  &#x000a9; 2009 Chen et al; licensee BioMed Central Ltd.</div><div class="license half_rhythm"><p id="__p1">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/2.0" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CFront%20Matter&amp;TO=External%7CLink%7CURI" target="_blank">http://creativecommons.org/licenses/by/2.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2739531/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm139878652542896" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139878652542896title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p2" class="p p-first-last">The general enhanced expression of &#x003b1;<sub>1</sub>-antichymotrypsin (ACT), clusterin (CLU), &#x003b1;<sub>1</sub>-antitrypsin (AAT), haptoglobin &#x003b2;-chain (HAP), and leucine rich glycoprotein (LRG) in the sera of patients with epithelial ovarian carcinoma (EOCa) was recently reported. In the present study, we compared the expression of the serum acute-phase proteins (APPs) in the patients according to their stages of cancer.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Results</h3><p id="__p3" class="p p-first-last">Different altered stage correlative expression of the high abundance serum APPs was demonstrated in sera of the patients studied. While the expression of ACT, HAP and AAT appeared to demonstrate positive correlation with the three initial stages of the cancer, inverse correlation was apparently detected in the expression of LRG and CLU. For patients who were diagnosed with stage IV of the cancer, expression of the serum APPs did not conform to the altered progression changes.</p></div><div id="__sec3" class="sec sec-last"><h3 id="__sec3title">Conclusion</h3><p id="__p4" class="p p-first-last">Our results highlight the potential prognostic significance of selective high abundance serum APPs in patients with EOCa.</p></div></div></div><div id="__sec4" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec4title">Background</h2><p id="__p5" class="p p-first">Epithelial ovarian carcinoma (EOCa) is usually asymptomatic in its early stages and development. For most patients, the disease is often widespread at the time of diagnosis, and this is partly due to the absence of sensitive and reliable serological markers. CA125, the currently accepted serum marker for diagnosis of EOCa, is limited in sensitivity as it is detected in approximately 50% of patients in stage I of the disease, and 80% of women with advanced cancer [<a href="#B1" rid="B1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586893">1</a>]. Moreover, it lacks specificity as it is also elevated in 30% of nonovarian malignancies, 6% of benign gynecologic disorders, and 1% of normal cases [<a href="#B2" rid="B2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586892">2</a>]. In addition, several gynecological disorders such as ovarian cysts, uterine leiomyomas, pelvis inflammatory disease and endometriosis produce higher levels of CA125 [<a href="#B3" rid="B3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586906">3</a>,<a href="#B4" rid="B4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586912">4</a>].</p><p id="__p6">Advances in proteomics analysis have generated much interest in the prospect of identifying complementary biomarkers for diagnoses of various cancers [<a href="#B5" rid="B5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586913">5</a>]. Our gel-based proteomic studies performed on unfractionated whole serum samples of patients with different types of cancer had demonstrated the different altered expression of selective serum high abundance acute-phase proteins (APPs) in sera of patients with EOCa [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586914">6</a>], germ-line ovarian carcinoma [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586881">6</a>], breast cancer [<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586905">7</a>], nasopharyngeal carcinoma [<a href="#B8" rid="B8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586908">8</a>], endometrial adenocarcinoma [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586895">9</a>], squamous cell cervical carcinoma [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586888">9</a>], adenocervical carcinoma [<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586910">9</a>] and osteosarcoma [<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586907">10</a>]. In the case of EOCa, enhanced expression of &#x003b1;1-antichymotrypsin (ACT), clusterin (CLU), &#x003b1;1-antitrypsin (AAT) and its fragments (AATf), haptoglobin &#x003b2;-chain (HAP) as well as its cleaved fragments (HAPc) and leucine rich glycoprotein (LRG) was detected in serum samples of the cancer patients compared to control individuals.</p><p id="__p7" class="p p-last">In the present study, the expression of the overexpressed high abundance acute-phase proteins (APPs) in sera of the EOCa patients was analysed according to the stages of the cancer.</p></div><div id="__sec5" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec5title">Methods</h2><div id="__sec6" class="sec sec-first"><h3 id="__sec6title">Serum samples</h3><p id="__p8" class="p p-first-last">Serum samples were obtained from newly diagnosed EOCa patients (ages between 24 to 65 years) in different stages of the cancer (stage I, n = 4; stage II, n = 6; stage III, n = 6; stage IV, n = 4) at the University of Malaya Medical Centre (UMMC), prior to treatment. Staging of EOCa was performed in accordance with the International Federation of Gynecology and Obstetrics (FIGO) clinical staging system. Control sera were obtained from 24 age-matched voluntary women without cancer. Samples obtained were with consent and approval granted by the Ethical committee (Institutional Review Board) of the UMMC in accordance with the Declaration of Helsinki and the ICH GCP guideline.</p></div><div id="__sec7" class="sec"><h3 id="__sec7title">Two-dimensional gel electrophoresis</h3><p id="__p9" class="p p-first-last">Two-dimensional gel electrophoresis (2-DE) was performed as previously described [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586884">6</a>-<a href="#B10" rid="B10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586909">10</a>]. Unfractionated whole human serum samples (10 &#x003bc;l) were subjected to isoelectric focusing in rehydrated precast immobilized dry strips pH 4-7 (GE Healthcare Bio-Sciences, Uppsala, Sweden). Focused samples in the strips were then subjected to electrophoresis using 8-18% gradient polyacrylamide gels in the presence of sodium dodecyl sulfate (SDS-PAGE). All samples were analyzed in duplicate.</p></div><div id="__sec8" class="sec"><h3 id="__sec8title">Staining of 2-DE gels</h3><p id="__p10" class="p p-first-last">The 2-DE gels were developed by silver staining as described by Heukeshoven and Dernick [<a href="#B11" rid="B11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586919">11</a>]. For mass spectrometric analysis, gels were stained with Coomassie Blue according to the modified method of Shevchenko <em>et al</em>. [<a href="#B12" rid="B12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586887">12</a>].</p></div><div id="__sec9" class="sec"><h3 id="__sec9title">Identification of proteins and database search</h3><p id="__p11" class="p p-first-last">Confirmation on the identities of the APP spot clusters by mass spectrometry using the Ettan MALDI-ToF Pro had been previously described [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586899">6</a>-<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586890">9</a>]. Peaklist data obtained from PMF were generated using the Ettan MALDI software (release version 2.0) and 4000 Series Explorer software (release version 3), respectively. The data were exported to the MASCOT search engine (Matrix Science Ltd., London, UK; release version 2.2). The following parameters were used in the search: (i) enzyme: trypsin, (ii) one missed cleavage allowed, (iii) taxonomy limited to <em>Homo sapiens</em>, (iv) mass value: monoisotopic, (v) peptide mass tolerance: &#x000b1; 0.1 Da and (vi) peptide charge state: 1+.</p></div><div id="__sec10" class="sec"><h3 id="__sec10title">Image analysis</h3><p id="__p12" class="p p-first-last">Images of the 2-DE gels were captured using the LabScan image scanner (Version 5). Protein profiles were evaluated using the ImageMaster&#x02122; 2D Platinum Software (Version 5). To eliminate possible variations due to differential protein staining and loading, expression of proteins was evaluated in percentage of volume contribution (%vol), which refers to the volume percentage of a protein taken against the total spot volume of all proteins.</p></div><div id="__sec11" class="sec sec-last"><h3 id="__sec11title">Statistical analysis</h3><p id="__p13" class="p p-first-last">Levels of proteins in the gels are presented as means %vol &#x000b1; SD of the respective number of samples in each cohort of patients or controls analysed. The Normal test (Z) was used to analyze the significance of differences between control subjects and patients and to examine the correlation between variables. A <em>P</em>-value of less than 0.05 (p &#x0003c; 0.05) was considered statistically significant.</p></div></div><div id="__sec12" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec12title">Results</h2><div id="__sec13" class="sec sec-first"><h3 id="__sec13title">Serum protein profiles</h3><p id="__p14" class="p p-first">Subjecting unfractionated serum samples of EOCa patients and negative control female subjects to 2-DE and silver staining generated typical highly resolved profiles of the high abundance proteins. Fig. <a href="/pmc/articles/PMC2739531/figure/F1/" target="figure" class="fig-table-link figpopup" rid-figpopup="F1" rid-ob="ob-F1" co-legend-rid="lgnd_F1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2em;">Fig.1</span></span><span>1</span></a> demonstrates the representative 2-DE serum protein profiles of the negative control women (panel A) and EOCa patients in various stages of the disease (panels B-E). Confirmation of the identities of the various serum high abundance APPs had been described in our previous reports [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586885">6</a>-<a href="#B9" rid="B9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586902">9</a>]. ACT, AAT, LRG, CLU and HAP spots clusters were clearly resolved in all profiles. However, HAPc and AATf appeared to be detected only in the sera of the EOCa patients but not in control individuals, while CLU was only detected in sera of patients in stages I and II (panels B and C, respectively), but not those in stages III and IV, and the negative control women.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F1" co-legend-rid="lgnd_F1"><a href="/pmc/articles/PMC2739531/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139878638495776" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2739531_1756-8722-2-37-1.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1756-8722-2-37-1.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2739531/bin/1756-8722-2-37-1.jpg" /></a></div><div id="largeobj_idm139878638495776" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2739531/figure/F1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F1"><div><a class="figpopup" href="/pmc/articles/PMC2739531/figure/F1/" target="figure" rid-figpopup="F1" rid-ob="ob-F1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p15"><strong>Typical 2-DE serum protein profiles of negative control women and patients in different stages of EOCa</strong>. Unfractionated serum samples of patients and negative controls were subjected to 2-DE and silver staining. Panel A demonstrates a typical representative 2-DE serum protein profile of negative control women. Panels B, C, D and E demonstrate typical representative unfractionated serum protein profiles of the patients with EOCa in stages I, II, III and IV, respectively. For all panels, the acidic sides of the 2-DE gels are to the left and relative molecular mass declines from the top.</p></div></div></div></div><div id="__sec14" class="sec sec-last"><h3 id="__sec14title">Image analysis of 2-DE gels</h3><p id="__p16" class="p p-first">When the clusters of the high abundance serum protein spots from control women and cohorts of patients diagnosed with different stages of EOCa were analyzed by densitometry software, the correlative stage associated expression of the APPs was demonstrated in sera of the patients studied. An inverse correlation with the initial three stages of the cancer was apparently detected in the expression of CLU and LRG (Fig. <a href="/pmc/articles/PMC2739531/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2,</span></span><span>2</span></a>, panels A and B, respectively). However, the expression of ACT, HAP and AAT appeared to be increasing with the first three stages of EOCa (Fig. <a href="/pmc/articles/PMC2739531/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2,</span></span><span>2</span></a>, panels C, D and E, respectively). For patients who were diagnosed with stage IV of the cancer, expression of the serum APPs did not conform to the altered progression changes. The expression of HAPc and AATf did not demonstrate any correlation with all stages of EOCa (Fig. <a href="/pmc/articles/PMC2739531/figure/F2/" target="figure" class="fig-table-link figpopup" rid-figpopup="F2" rid-ob="ob-F2" co-legend-rid="lgnd_F2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">(Fig.2,</span></span><span>2</span></a>, panels F and G, respectively). The relative expressions (fold changes and statistical significance) of the serum high abundance proteins in EOCa patients according to the stage of cancer are summarized in Table <a href="/pmc/articles/PMC2739531/table/T1/" target="table" class="fig-table-link figpopup" rid-figpopup="T1" rid-ob="ob-T1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1</span></span><span>1</span></a>.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="T1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p17">Relative expression of APPs in the sera of patients in different clinical stages of EOCa.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139878652149392" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="center" rowspan="1" colspan="1"><strong>Serum proteins</strong></td><td align="center" colspan="4" rowspan="1"><strong>*Fold changes and statistical significance</strong></td><td align="center" rowspan="1" colspan="1"><strong>Probability <em>P</em></strong></td></tr><tr><td rowspan="1" colspan="1"></td><td colspan="4" rowspan="1"><hr /></td><td rowspan="1" colspan="1"></td></tr><tr><td rowspan="1" colspan="1"></td><td align="center" rowspan="1" colspan="1"><strong>Stage I</strong></td><td align="center" rowspan="1" colspan="1"><strong>Stage II</strong></td><td align="center" rowspan="1" colspan="1"><strong>Stage III</strong></td><td align="center" rowspan="1" colspan="1"><strong>Stage IV</strong></td><td rowspan="1" colspan="1"></td></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1"><strong>CLU</strong></td><td align="center" rowspan="1" colspan="1">#</td><td align="center" rowspan="1" colspan="1">#</td><td align="center" rowspan="1" colspan="1">nd</td><td align="center" rowspan="1" colspan="1">nd</td><td align="center" rowspan="1" colspan="1">0.0004</td></tr><tr><td align="center" rowspan="1" colspan="1"><strong>LRG</strong></td><td align="center" rowspan="1" colspan="1">+23.36-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+16.46-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+6.44-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+15.34-fold;<br /><em>p </em>= 0.0128</td><td align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="center" rowspan="1" colspan="1"><strong>ACT</strong></td><td align="center" rowspan="1" colspan="1">+2.65-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+3.94-fold;<br /><em>p </em>= 0.0006</td><td align="center" rowspan="1" colspan="1">+5.50-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">ns</td><td align="center" rowspan="1" colspan="1">0.2177</td></tr><tr><td align="center" rowspan="1" colspan="1"><strong>HAP</strong></td><td align="center" rowspan="1" colspan="1">+2.24-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+2.84-fold;<br /><em>p </em>= 0.0004</td><td align="center" rowspan="1" colspan="1">+6.78-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">ns</td><td align="center" rowspan="1" colspan="1">0.0001</td></tr><tr><td align="center" rowspan="1" colspan="1"><strong>AAT</strong></td><td align="center" rowspan="1" colspan="1">+2.52-fold;<em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+3.35-fold;<em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+4.09-fold;<em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+4.75-fold;<em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">0.0008</td></tr><tr><td align="center" rowspan="1" colspan="1"><strong>HAPc</strong></td><td align="center" rowspan="1" colspan="1">#</td><td align="center" rowspan="1" colspan="1">#</td><td align="center" rowspan="1" colspan="1">#</td><td align="center" rowspan="1" colspan="1">#</td><td align="center" rowspan="1" colspan="1">0.0757</td></tr><tr><td align="center" rowspan="1" colspan="1"><strong>AATf</strong></td><td align="center" rowspan="1" colspan="1">+7.30-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+8.91-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+8.12-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">+14.14-fold;<br /><em>p </em>= 0.0001</td><td align="center" rowspan="1" colspan="1">0.0388</td></tr></tbody></table></div><div id="largeobj_idm139878652149392" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2739531/table/T1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p18">*Fold change measures the degree of change in protein expression in patients compared to that of negative controls. This is measured by dividing the average spot intensity in the patients by average spot intensity in the control.</p><p id="__p19"># exclusive detection in patients (not detected in negative controls)</p><p id="__p20">ns protein not significantly expressed</p><p id="__p21">nd protein not detected</p><p id="__p22">+ increased in expression</p><p id="__p23">-- decreased in expression</p></div></div><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="F2" co-legend-rid="lgnd_F2"><a href="/pmc/articles/PMC2739531/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm139878654294816" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2739531_1756-8722-2-37-2.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is 1756-8722-2-37-2.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2739531/bin/1756-8722-2-37-2.jpg" /></a></div><div id="largeobj_idm139878654294816" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2739531/figure/F2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_F2"><div><a class="figpopup" href="/pmc/articles/PMC2739531/figure/F2/" target="figure" rid-figpopup="F2" rid-ob="ob-F2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p24"><strong>Mean percentage of volume contribution of APPs expression in negative control women and patients in different stages of EOCa</strong>. Percentage of volume contribution (%vol) of APPs spot clusters were analyzed by ImageMaster&#x02122; 2D Platinum Software Version 5. Analysis was performed on the spot clusters of A:CLU, B:LRG, C:ACT, D:HAP, E:AAT, F:HAPc, and G:AATf. I, II, III and IV refer to the various stages of EOCa in patients, while NC refers to the negative control. Results are means &#x000b1; SD of the respective number of samples in each cohort analysed (stage I, n = 4; stage II, n = 6; stage III, n = 6; stage IV, n = 4; negative control, n = 24). Summary of the relative expression of serum proteins analysed is presented in Table 1. Asterisks denote significantly different values (p &#x0003c; 0.05).</p></div></div></div></div></div><div id="__sec15" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec15title">Discussion</h2><p id="__p25" class="p p-first">The results of our experiments highlight the potential prognostic significance of several aberrantly expressed APPs, and hence, the need to conduct a study to monitor the expression of the serum proteins with progress of EOCa. In the present study, we demonstrated the correlative expression of ACT, CLU, HAP, AAT and LRG in patients with EOCa in accordance to the three initial stages of the cancer by using the gel-based proteomics approach. However, the stage-correlated expression was not observed for HAPc and AATf, although the protein fragments were generally not detected in the 2-DE protein profiles of normal control women. Unlike the initial three stages of EOCa, the expression of ACT, CLU, HAP, AAT and LRG in sera of EOCa patients in stage IV did not conform to the altered progression changes observed. This was not unexpected, as the APPs response is generally expected to succumb to the malignancy at the final stage of the cancer, and thus affecting their synthesis in the liver. Depending on severity of the malignancy and liver damage in the late stage patients, the levels of the APPs may or may not correlate with the patterns of the altered progression changes.</p><p id="__p26">The correlative expression of high abundance serum APPs that were detected in the present study may be reflective of the acute-phase response of the body at various initial stages of EOCa. The up-regulated expression of CLU in early stages of EOCa may function to suppress the biologically aggressive behavior of the cancer cells and to exert a protective function on surviving cells. CLU has been reported to confer protection against various cytotoxic agents such as UV radiation, heat shock, oxidative stress, TNF&#x003b1; and chemotherapeutic drugs [<a href="#B13" rid="B13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586901">13</a>-<a href="#B15" rid="B15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586886">15</a>]. In cases of the non small cell lung and breast cancers, the expression of CLU was demonstrated to be significantly associated with relapse-free and metastasis-free survival of patients [<a href="#B16" rid="B16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586900">16</a>,<a href="#B17" rid="B17" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586916">17</a>]. Taken together with the data of our present study, this is suggestive of the prognostic significance of CLU in the cancers concerned.</p><p id="__p27">Like CLU, our present study demonstrated that the enhanced expression of LRG appeared to be inversely correlated with progression of EOCa. LRG, whose function is unknown, was consistently elevated in sera of patients with bacterial infections and often increased during viral infections [<a href="#B18" rid="B18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586911">18</a>]. Patients with severe acute-phase respiratory syndrome were also noted for their enhanced levels of serum LRG [<a href="#B19" rid="B19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586915">19</a>]. In the case of cancer, increased serum LRG has been observed in patients with liver [<a href="#B20" rid="B20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586920">20</a>], lung [<a href="#B21" rid="B21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586883">21</a>] and pancreatic [<a href="#B22" rid="B22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_847064566">22</a>] cancers. Together with HAP, it is also one of the few high abundance cancer selective proteins that were identified in a study comparing trypsin-digested peptides of glycoproteins isolated from sera of healthy individuals and lung adenocarcinoma patients [<a href="#B23" rid="B23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586918">23</a>]. Aside from its potential as a biomarker for diagnosis, the data of our present study further suggests the prognostic value of LRG particularly for EOCa.</p><p id="__p28">ACT is a well-established APP, whose function is primarily associated with inflammation [<a href="#B24" rid="B24" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586896">24</a>]. It\'s levels have previously been reported to be elevated in sera of patients with EOCa [<a href="#B6" rid="B6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586898">6</a>], breast cancer [<a href="#B7" rid="B7" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586891">7</a>], and pancreatic cancer [<a href="#B25" rid="B25" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586889">25</a>,<a href="#B26" rid="B26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586882">26</a>]. Since the serine proteinase inhibitor is known to form a complex with human kallikrein 3 (HK3; also known as prostate-specific antigen) [<a href="#B27" rid="B27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586897">27</a>], and HK3 has been shown to be produced by a number of tumors including the ovarian tumor [<a href="#B28" rid="B28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586904">28</a>], it is very likely that the excess ACT detected in sera of the EOCa patients was part of a complex with HK3 or other proteins. However, this could not be verified since the gel-based approach adopted in our studies involved analysis of proteins in their denatured forms.</p><p id="__p29">The expression of HAP appeared to peak in stage III of EOCa. A recent report by Zhao <em>et al</em>. also demonstrated that circulating HAP was significantly correlated with the stage of tumor and survival of EOCa patients [<a href="#B29" rid="B29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586917">29</a>]. These accumulated data imply that the expression of HAP had been affected by the tumor burden. The significant up-regulated expression of HAPc in the sera of EOCa patients in all stages observed in the present study suggests that the cancer associated HAP was rather unstable and prone to proteolysis. However, the generation of HAPc did not appear to correlate with the various stages of EOCa.</p><p id="__p30" class="p p-last">Previously reported studies performed on lung, breast and cervical cancer patients have indicated correlative changes in the levels of serum or plasma AAT, especially in the late metastatic stages of the disease [<a href="#B30" rid="B30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586903">30</a>-<a href="#B32" rid="B32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_179586894">32</a>]. This is compatible with the data of our present study. The significant enhanced expression of AAT in patients with EOCa in all stages also provides explanation to the detection of its cleaved fragment spots, AATf, exclusively in samples from patients. The lower molecular weight AATf was likely generated by proteolytic digestion of the abundant AAT within the cancer microenvironment. Like HAPc, however, cleavage of the serum protein did not appear to correlate with the stages of EOCa.</p></div><div id="__sec16" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec16title">Conclusion</h2><p id="__p31" class="p p-first-last">The different altered stage correlative expression of CLU, LRG, ACT, HAP and AAT in sera of patients with EOCa was demonstrated in the present study. Our results highlight the potential prognostic significance of the high abundance serum APPs in patients with EOCa.</p></div><div id="__sec17" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec17title">Competing interests</h2><p id="__p32" class="p p-first-last">The authors declare that they have no competing interests.</p></div><div id="__sec18" class="tsec sec"><h2 class="head no_bottom_margin" id="__sec18title">Authors\' contributions</h2><p id="__p33" class="p p-first-last">YC carried out the experiments and analyzed the data. BKL provided the serum samples for the study and shared his clinical expertise on epithelial ovarian carcinoma. OHH conceptualized the study, designed it and authored the manuscript. All authors read and approved the final manuscript.</p></div><div id="idm139878602245088" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139878602245088title">Acknowledgements</h2><div class="sec"><div id="__sec19" class="sec sec-first"><h3 id="__sec19title"></h3><p id="__p34" class="p p-first-last">This work was funded by research grants from the University of Malaya (RG011/09AFR) and the Ministry of Science, Technology and Innovation, Malaysia (IRPA grant 12-02-03-2021).</p></div></div></div><div id="idm139878602243648" class="tsec sec"><h2 class="head no_bottom_margin" id="idm139878602243648title">References</h2><div class="ref-list-sec sec" id="reference-list"><ul class="back-ref-list" style="list-style-type:decimal;"><li id="B1"><span class="citation">Ginath S, Menczer J, Fintsi Y, Ben-Shem E, Glezerman M, Avinoach I. Tissue and serum CA125 expression in endometrial cancer. <span><span class="ref-journal">Int J Gynecol Cancer. </span>2002;<span class="ref-vol">12</span>:372\xe2\x80\x93375. doi: 10.1046/j.1525-1438.2002.01007.x.</span> [<a href="/pubmed/12144685" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1046%2Fj.1525-1438.2002.01007.x" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Int+J+Gynecol+Cancer&amp;title=Tissue+and+serum+CA125+expression+in+endometrial+cancer&amp;author=S+Ginath&amp;author=J+Menczer&amp;author=Y+Fintsi&amp;author=E+Ben-Shem&amp;author=M+Glezerman&amp;volume=12&amp;publication_year=2002&amp;pages=372-375&amp;pmid=12144685&amp;doi=10.1046/j.1525-1438.2002.01007.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B2"><span class="citation">Bast RC, Jr, Klug TL, St John E, Jenison E, Niloff JM, Lazarus H, Berkowitz RS, Leavitt T, Griffiths CT, Parker L, Zurawski VR, Jr, Knapp RC. A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer. <span><span class="ref-journal">N Engl J Med. </span>1983;<span class="ref-vol">309</span>:883\xe2\x80\x93887.</span> [<a href="/pubmed/6310399" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+radioimmunoassay+using+a+monoclonal+antibody+to+monitor+the+course+of+epithelial+ovarian+cancer&amp;author=RC+Bast&amp;author=TL+Klug&amp;author=E+St+John&amp;author=E+Jenison&amp;author=JM+Niloff&amp;volume=309&amp;publication_year=1983&amp;pages=883-887&amp;pmid=6310399&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B3"><span class="citation">Jacobs IJ, Bast RC., Jr The CA125 tumor associated antigen: a review of the literature. <span><span class="ref-journal">Hum Reprod. </span>1989;<span class="ref-vol">4</span>:1\xe2\x80\x9312.</span> [<a href="/pubmed/2651469" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hum+Reprod&amp;title=The+CA125+tumor+associated+antigen:+a+review+of+the+literature&amp;author=IJ+Jacobs&amp;author=RC+Bast&amp;volume=4&amp;publication_year=1989&amp;pages=1-12&amp;pmid=2651469&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B4"><span class="citation">MacDonald D, Stockwin L, Matzow T, Zajdel MB, Blair G. Coxsackie and adenovirus receptor (CAR)-dependent and major MHC class 1-dependent uptake of recombinant adenoviruses into human tumour cells. <span><span class="ref-journal">Gene Ther. </span>1999;<span class="ref-vol">6</span>:1512\xe2\x80\x931519. doi: 10.1038/sj.gt.3301006.</span> [<a href="/pubmed/10490760" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fsj.gt.3301006" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Gene+Ther&amp;title=Coxsackie+and+adenovirus+receptor+(CAR)-dependent+and+major+MHC+class+1-dependent+uptake+of+recombinant+adenoviruses+into+human+tumour+cells&amp;author=D+MacDonald&amp;author=L+Stockwin&amp;author=T+Matzow&amp;author=MB+Zajdel&amp;author=G+Blair&amp;volume=6&amp;publication_year=1999&amp;pages=1512-1519&amp;pmid=10490760&amp;doi=10.1038/sj.gt.3301006&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B5"><span class="citation">Krieg RC, Paweletz CP, Liotta LA, Petricoin EF., III Clinical proteomics for cancer biomarker discovery and therapeutic targeting. <span><span class="ref-journal">Technol Cancer Res Treat. </span>2002;<span class="ref-vol">1</span>:263\xe2\x80\x93272.</span> [<a href="/pubmed/12625785" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Technol+Cancer+Res+Treat&amp;title=Clinical+proteomics+for+cancer+biomarker+discovery+and+therapeutic+targeting&amp;author=RC+Krieg&amp;author=CP+Paweletz&amp;author=LA+Liotta&amp;author=EF+Petricoin&amp;volume=1&amp;publication_year=2002&amp;pages=263-272&amp;pmid=12625785&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B6"><span class="citation">Chen Y, Lim BK, Peh SC, Abdul-Rahman PS, Hashim OH. Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma. <span><span class="ref-journal">Proteome Sci. </span>2008;<span class="ref-vol">6</span>:20. doi: 10.1186/1477-5956-6-20.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2496906/">PMC free article</a>]</span> [<a href="/pubmed/18637207" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1477-5956-6-20" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proteome+Sci&amp;title=Profiling+of+serum+and+tissue+high+abundance+acute-phase+proteins+of+patients+with+epithelial+and+germ+line+ovarian+carcinoma&amp;author=Y+Chen&amp;author=BK+Lim&amp;author=SC+Peh&amp;author=PS+Abdul-Rahman&amp;author=OH+Hashim&amp;volume=6&amp;publication_year=2008&amp;pages=20&amp;pmid=18637207&amp;doi=10.1186/1477-5956-6-20&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B7"><span class="citation">Doustjalali SR, Yusof R, Yip CH, Looi LM, Pillay B, Hashim OH. Aberrant expression of acute-phase reactant proteins in sera and breast lesions from patients with malignant and benign breast tumours. <span><span class="ref-journal">Electrophoresis. </span>2004;<span class="ref-vol">25</span>:2392\xe2\x80\x932401. doi: 10.1002/elps.200305950.</span> [<a href="/pubmed/15274022" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Felps.200305950" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Electrophoresis&amp;title=Aberrant+expression+of+acute-phase+reactant+proteins+in+sera+and+breast+lesions+from+patients+with+malignant+and+benign+breast+tumours&amp;author=SR+Doustjalali&amp;author=R+Yusof&amp;author=CH+Yip&amp;author=LM+Looi&amp;author=B+Pillay&amp;volume=25&amp;publication_year=2004&amp;pages=2392-2401&amp;pmid=15274022&amp;doi=10.1002/elps.200305950&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B8"><span class="citation">Doustjalali SR, Yusof R, Govindasamy GK, Bustam AZ, Pillay B, Hashim OH. Patients with nasopharyngeal carcinoma demonstrate enhanced serum and tissue ceruloplasmin expression. <span><span class="ref-journal">J Med Invest. </span>2006;<span class="ref-vol">53</span>:20\xe2\x80\x9328. doi: 10.2152/jmi.53.20.</span> [<a href="/pubmed/16537992" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2152%2Fjmi.53.20" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Med+Invest&amp;title=Patients+with+nasopharyngeal+carcinoma+demonstrate+enhanced+serum+and+tissue+ceruloplasmin+expression&amp;author=SR+Doustjalali&amp;author=R+Yusof&amp;author=GK+Govindasamy&amp;author=AZ+Bustam&amp;author=B+Pillay&amp;volume=53&amp;publication_year=2006&amp;pages=20-28&amp;pmid=16537992&amp;doi=10.2152/jmi.53.20&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B9"><span class="citation">Abdul-Rahman PS, Lim BK, Hashim OH. Expression of high abundance proteins in sera of patients with endometrial and cervical cancers: analysis using two-dimensional gel electrophoresis with silver staining and lectin detection methods. <span><span class="ref-journal">Electrophoresis. </span>2007;<span class="ref-vol">28</span>:1989\xe2\x80\x931996. doi: 10.1002/elps.200600629.</span> [<a href="/pubmed/17503403" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Felps.200600629" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Electrophoresis&amp;title=Expression+of+high+abundance+proteins+in+sera+of+patients+with+endometrial+and+cervical+cancers:+analysis+using+two-dimensional+gel+electrophoresis+with+silver+staining+and+lectin+detection+methods&amp;author=PS+Abdul-Rahman&amp;author=BK+Lim&amp;author=OH+Hashim&amp;volume=28&amp;publication_year=2007&amp;pages=1989-1996&amp;pmid=17503403&amp;doi=10.1002/elps.200600629&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B10"><span class="citation">Mohamed E, Abdul-Rahman PS, Doustjalali SR, Chen Y, Lim BK, Omar SZ, Bustam AZ, Singh VA, Muhammad-Taib NA, Yip CH, Hashim OH. Lectin-based electrophoretic analysis of the expression of the 35 kDa inter-alpha-trypsin inhibitor heavy chain H4 fragment in sera of patients with five different malignancies. <span><span class="ref-journal">Electrophoresis. </span>2008;<span class="ref-vol">29</span>:2645\xe2\x80\x932650. doi: 10.1002/elps.200700828.</span> [<a href="/pubmed/18494030" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Felps.200700828" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Electrophoresis&amp;title=Lectin-based+electrophoretic+analysis+of+the+expression+of+the+35+kDa+inter-alpha-trypsin+inhibitor+heavy+chain+H4+fragment+in+sera+of+patients+with+five+different+malignancies&amp;author=E+Mohamed&amp;author=PS+Abdul-Rahman&amp;author=SR+Doustjalali&amp;author=Y+Chen&amp;author=BK+Lim&amp;volume=29&amp;publication_year=2008&amp;pages=2645-2650&amp;pmid=18494030&amp;doi=10.1002/elps.200700828&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B11"><span class="citation">Heukeshoven J, Dernick R. Improved silver staining procedure for fast staining in PhastSystem development unit. I. Staining of sodium dodecyl sulphate gels. <span><span class="ref-journal">Electrophoresis. </span>1988;<span class="ref-vol">9</span>:28\xe2\x80\x9332. doi: 10.1002/elps.1150090106.</span> [<a href="/pubmed/2466645" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Felps.1150090106" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Electrophoresis&amp;title=Improved+silver+staining+procedure+for+fast+staining+in+PhastSystem+development+unit.+I.+Staining+of+sodium+dodecyl+sulphate+gels&amp;author=J+Heukeshoven&amp;author=R+Dernick&amp;volume=9&amp;publication_year=1988&amp;pages=28-32&amp;pmid=2466645&amp;doi=10.1002/elps.1150090106&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B12"><span class="citation">Shevchenko A, Wilm M, Vorm O, Mann M. Mass spectrometric sequencing of proteins from silver-stained polyacrylamide gels. <span><span class="ref-journal">Anal Chem. </span>1996;<span class="ref-vol">68</span>:850\xe2\x80\x93858. doi: 10.1021/ac950914h.</span> [<a href="/pubmed/8779443" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1021%2Fac950914h" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anal+Chem&amp;title=Mass+spectrometric+sequencing+of+proteins+from+silver-stained+polyacrylamide+gels&amp;author=A+Shevchenko&amp;author=M+Wilm&amp;author=O+Vorm&amp;author=M+Mann&amp;volume=68&amp;publication_year=1996&amp;pages=850-858&amp;pmid=8779443&amp;doi=10.1021/ac950914h&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B13"><span class="citation">Schwochau GB, Nath KA, Rosenberg ME. Clusterin protects against oxidative stress in vitro through aggregative and nonaggregative properties. <span><span class="ref-journal">Kidney Int. </span>1998;<span class="ref-vol">53</span>:1647\xe2\x80\x931653. doi: 10.1046/j.1523-1755.1998.00902.x.</span> [<a href="/pubmed/9607196" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1046%2Fj.1523-1755.1998.00902.x" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Kidney+Int&amp;title=Clusterin+protects+against+oxidative+stress+in+vitro+through+aggregative+and+nonaggregative+properties&amp;author=GB+Schwochau&amp;author=KA+Nath&amp;author=ME+Rosenberg&amp;volume=53&amp;publication_year=1998&amp;pages=1647-1653&amp;pmid=9607196&amp;doi=10.1046/j.1523-1755.1998.00902.x&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B14"><span class="citation">Miyake H, Nelson C, Rennie PS, Gleave ME. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. <span><span class="ref-journal">Cancer Res. </span>2000;<span class="ref-vol">60</span>:170\xe2\x80\x93176.</span> [<a href="/pubmed/10646870" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Testosterone-repressed+prostate+message-2+is+an+antiapoptotic+gene+involved+in+progression+to+androgen+independence+in+prostate+cancer&amp;author=H+Miyake&amp;author=C+Nelson&amp;author=PS+Rennie&amp;author=ME+Gleave&amp;volume=60&amp;publication_year=2000&amp;pages=170-176&amp;pmid=10646870&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B15"><span class="citation">Trougakos IP, Gonos GS. Functional analysis of clusterin/apolipoprotein J in cellular death induced by severe genotoxic stress. <span><span class="ref-journal">Ann N Y Acad Sci. </span>2004;<span class="ref-vol">1019</span>:206\xe2\x80\x93210. doi: 10.1196/annals.1297.033.</span> [<a href="/pubmed/15247015" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1196%2Fannals.1297.033" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Ann+N+Y+Acad+Sci&amp;title=Functional+analysis+of+clusterin/apolipoprotein+J+in+cellular+death+induced+by+severe+genotoxic+stress&amp;author=IP+Trougakos&amp;author=GS+Gonos&amp;volume=1019&amp;publication_year=2004&amp;pages=206-210&amp;pmid=15247015&amp;doi=10.1196/annals.1297.033&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B16"><span class="citation">Albert JM, Gonzalez A, Massion PP, Chen H, Olson SJ, Shyr Y, Diaz R, Lambright ES, Sandler A, Carbone DP, Putnam JB, Jr, Johnson DH, Lu B. Cytoplasmic clusterin expression is associated with longer survival in patients with resected non small cell lung cancer. <span><span class="ref-journal">Cancer Epidemiol Biomarkers Prev. </span>2007;<span class="ref-vol">16</span>:1845\xe2\x80\x931851. doi: 10.1158/1055-9965.EPI-07-0146.</span> [<a href="/pubmed/17855704" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1158%2F1055-9965.EPI-07-0146" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Epidemiol+Biomarkers+Prev&amp;title=Cytoplasmic+clusterin+expression+is+associated+with+longer+survival+in+patients+with+resected+non+small+cell+lung+cancer&amp;author=JM+Albert&amp;author=A+Gonzalez&amp;author=PP+Massion&amp;author=H+Chen&amp;author=SJ+Olson&amp;volume=16&amp;publication_year=2007&amp;pages=1845-1851&amp;pmid=17855704&amp;doi=10.1158/1055-9965.EPI-07-0146&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B17"><span class="citation">Kr&#x000fc;ger S, Ola V, Fischer D, Feller AC, Friedrich M. Prognostic significance of clusterin immunoreactivity in breast cancer. <span><span class="ref-journal">Neoplasma. </span>2007;<span class="ref-vol">54</span>:46\xe2\x80\x9350.</span> [<a href="/pubmed/17203891" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasma&amp;title=Prognostic+significance+of+clusterin+immunoreactivity+in+breast+cancer&amp;author=S+Kr&#x000fc;ger&amp;author=V+Ola&amp;author=D+Fischer&amp;author=AC+Feller&amp;author=M+Friedrich&amp;volume=54&amp;publication_year=2007&amp;pages=46-50&amp;pmid=17203891&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B18"><span class="citation">Bini L, Magi B, Marzocchi B, Cellesi C, Berti B, Raggiaschi R, Rossolini A, Pallini V. Two-dimensional electrophoretic patterns of acute-phase human serum proteins in the course of bacterial and viral diseases. <span><span class="ref-journal">Electrophoresis. </span>1996;<span class="ref-vol">17</span>:612\xe2\x80\x93616. doi: 10.1002/elps.1150170333.</span> [<a href="/pubmed/8740187" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Felps.1150170333" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Electrophoresis&amp;title=Two-dimensional+electrophoretic+patterns+of+acute-phase+human+serum+proteins+in+the+course+of+bacterial+and+viral+diseases&amp;author=L+Bini&amp;author=B+Magi&amp;author=B+Marzocchi&amp;author=C+Cellesi&amp;author=B+Berti&amp;volume=17&amp;publication_year=1996&amp;pages=612-616&amp;pmid=8740187&amp;doi=10.1002/elps.1150170333&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B19"><span class="citation">Chen JH, Chang YW, Yao CW, Chiueh TS, Huang SC, Chien KY. Plasma proteome of severe acute respiratory syndrome analyzed by two-dimensional electrophoresis and mass spectrometry. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2004;<span class="ref-vol">101</span>:17039\xe2\x80\x9317044. doi: 10.1073/pnas.0407992101.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC535397/">PMC free article</a>]</span> [<a href="/pubmed/15572443" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0407992101" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Plasma+proteome+of+severe+acute+respiratory+syndrome+analyzed+by+two-dimensional+electrophoresis+and+mass+spectrometry&amp;author=JH+Chen&amp;author=YW+Chang&amp;author=CW+Yao&amp;author=TS+Chiueh&amp;author=SC+Huang&amp;volume=101&amp;publication_year=2004&amp;pages=17039-17044&amp;pmid=15572443&amp;doi=10.1073/pnas.0407992101&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B20"><span class="citation">Kawakami T, Hoshida Y, Kanai F, Tanaka Y, Tateishi K, Ikenoue T, Obi S, Sato S, Teratani T, Shiina S, Kawabe T, Suzuki T, Hatano N, Taniguchi H, Omata M. Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment. <span><span class="ref-journal">Proteomics. </span>2005;<span class="ref-vol">5</span>:4287\xe2\x80\x934295. doi: 10.1002/pmic.200401287.</span> [<a href="/pubmed/16254924" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fpmic.200401287" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proteomics&amp;title=Proteomic+analysis+of+sera+from+hepatocellular+carcinoma+patients+after+radiofrequency+ablation+treatment&amp;author=T+Kawakami&amp;author=Y+Hoshida&amp;author=F+Kanai&amp;author=Y+Tanaka&amp;author=K+Tateishi&amp;volume=5&amp;publication_year=2005&amp;pages=4287-4295&amp;pmid=16254924&amp;doi=10.1002/pmic.200401287&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B21"><span class="citation">Okano T, Kondo T, Kakisaka T, Fujii K, Yamada M, Kato H, Nishimura T, Gemma A, Kudoh S, Hirohashi S. Plasma proteomics of lung cancer by linkage of multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis. <span><span class="ref-journal">Proteomics. </span>2006;<span class="ref-vol">6</span>:3938\xe2\x80\x933948. doi: 10.1002/pmic.200500883.</span> [<a href="/pubmed/16767791" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fpmic.200500883" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proteomics&amp;title=Plasma+proteomics+of+lung+cancer+by+linkage+of+multi-dimensional+liquid+chromatography+and+two-dimensional+difference+gel+electrophoresis&amp;author=T+Okano&amp;author=T+Kondo&amp;author=T+Kakisaka&amp;author=K+Fujii&amp;author=M+Yamada&amp;volume=6&amp;publication_year=2006&amp;pages=3938-3948&amp;pmid=16767791&amp;doi=10.1002/pmic.200500883&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B22"><span class="citation">Kakisaka T, Kondo T, Okano T, Fujii K, Honda K, Endo M, Tsuchida A, Aoki T, Itoi T, Moriyasu F, Yamada M, Kato H, Nishimura T, Todo S, Hirohashi S. Plasma proteomics of pancreatic cancer patients by multi-dimensional liquid chromatography and two-dimensional difference gel electrophoresis (2D-DIGE): up-regulation of leucine-rich alpha-2-glycoprotein in pancreatic cancer. <span><span class="ref-journal">J Chromatogr B Biomed Sci Appl. </span>2007;<span class="ref-vol">852</span>:257\xe2\x80\x93267. doi: 10.1016/j.jchromb.2007.01.029.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7105233/">PMC free article</a>]</span> [<a href="/pubmed/17303479" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.jchromb.2007.01.029" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Chromatogr+B+Biomed+Sci+Appl&amp;title=Plasma+proteomics+of+pancreatic+cancer+patients+by+multi-dimensional+liquid+chromatography+and+two-dimensional+difference+gel+electrophoresis+(2D-DIGE):+up-regulation+of+leucine-rich+alpha-2-glycoprotein+in+pancreatic+cancer&amp;author=T+Kakisaka&amp;author=T+Kondo&amp;author=T+Okano&amp;author=K+Fujii&amp;author=K+Honda&amp;volume=852&amp;publication_year=2007&amp;pages=257-267&amp;doi=10.1016/j.jchromb.2007.01.029&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B23"><span class="citation">Heo SH, Lee SJ, Ryoo HM, Park JY, Cho JY. Identification of putative serum glycoprotein biomarkers for human lung adenocarcinoma by multilectin affinity chromatography and LC-MS/MS. <span><span class="ref-journal">Proteomics. </span>2007;<span class="ref-vol">7</span>:4292\xe2\x80\x934302. doi: 10.1002/pmic.200700433.</span> [<a href="/pubmed/17963278" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fpmic.200700433" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proteomics&amp;title=Identification+of+putative+serum+glycoprotein+biomarkers+for+human+lung+adenocarcinoma+by+multilectin+affinity+chromatography+and+LC-MS/MS&amp;author=SH+Heo&amp;author=SJ+Lee&amp;author=HM+Ryoo&amp;author=JY+Park&amp;author=JY+Cho&amp;volume=7&amp;publication_year=2007&amp;pages=4292-4302&amp;pmid=17963278&amp;doi=10.1002/pmic.200700433&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B24"><span class="citation">Baker C, Belbin O, Kalsheker N, Morgan K. SERPINA3 (aka alpha-1-antichymotrypsin) <span><span class="ref-journal">Front Biosci. </span>2007;<span class="ref-vol">12</span>:2821\xe2\x80\x932835. doi: 10.2741/2275.</span> [<a href="/pubmed/17485262" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.2741%2F2275" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Front+Biosci&amp;title=SERPINA3+(aka+alpha-1-antichymotrypsin)&amp;author=C+Baker&amp;author=O+Belbin&amp;author=N+Kalsheker&amp;author=K+Morgan&amp;volume=12&amp;publication_year=2007&amp;pages=2821-2835&amp;pmid=17485262&amp;doi=10.2741/2275&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B25"><span class="citation">Koomen JM, Shih LN, Coombes KR, Li D, Xiao LC, Fidler IJ, Abbruzzese JL, Kobayashi R. Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. <span><span class="ref-journal">Clin Cancer Res. </span>2005;<span class="ref-vol">11</span>:1110\xe2\x80\x931118.</span> [<a href="/pubmed/15709178" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Cancer+Res&amp;title=Plasma+protein+profiling+for+diagnosis+of+pancreatic+cancer+reveals+the+presence+of+host+response+proteins&amp;author=JM+Koomen&amp;author=LN+Shih&amp;author=KR+Coombes&amp;author=D+Li&amp;author=LC+Xiao&amp;volume=11&amp;publication_year=2005&amp;pages=1110-1118&amp;pmid=15709178&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B26"><span class="citation">Yu KH, Rustgi AK, Blair IA. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. <span><span class="ref-journal">J Proteome Res. </span>2005;<span class="ref-vol">4</span>:1742\xe2\x80\x931751. doi: 10.1021/pr050174l.</span> [<a href="/pubmed/16212428" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1021%2Fpr050174l" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Proteome+Res&amp;title=Characterization+of+proteins+in+human+pancreatic+cancer+serum+using+differential+gel+electrophoresis+and+tandem+mass+spectrometry&amp;author=KH+Yu&amp;author=AK+Rustgi&amp;author=IA+Blair&amp;volume=4&amp;publication_year=2005&amp;pages=1742-1751&amp;pmid=16212428&amp;doi=10.1021/pr050174l&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B27"><span class="citation">Lilja H. Biology of prostate-specific antigen. <span><span class="ref-journal">Urology. </span>2003;<span class="ref-vol">62</span>:27\xe2\x80\x9333. doi: 10.1016/S0090-4295(03)00775-1.</span> [<a href="/pubmed/14607215" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0090-4295(03)00775-1" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Urology&amp;title=Biology+of+prostate-specific+antigen&amp;author=H+Lilja&amp;volume=62&amp;publication_year=2003&amp;pages=27-33&amp;pmid=14607215&amp;doi=10.1016/S0090-4295(03)00775-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B28"><span class="citation">Kapadia C, Yousef GM, Mellati AA, Magklara A, Wasney GA, Diamandis EP. Prostate-specific antigen expression by various tumors. <span><span class="ref-journal">J Clin Lab Anal. </span>1995;<span class="ref-vol">9</span>:123\xe2\x80\x93128. doi: 10.1002/jcla.1860090209.</span> [<a href="/pubmed/7536238" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2Fjcla.1860090209" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Clin+Lab+Anal&amp;title=Prostate-specific+antigen+expression+by+various+tumors&amp;author=C+Kapadia&amp;author=GM+Yousef&amp;author=AA+Mellati&amp;author=A+Magklara&amp;author=GA+Wasney&amp;volume=9&amp;publication_year=1995&amp;pages=123-128&amp;pmid=7536238&amp;doi=10.1002/jcla.1860090209&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B29"><span class="citation">Zhao C, Annamalai L, Guo C, Kothandaraman N, Koh SC, Zhang H, Biswas A, Choolani M. Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer. <span><span class="ref-journal">Neoplasia. </span>2007;<span class="ref-vol">9</span>:1\xe2\x80\x937. doi: 10.1593/neo.06619.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1803031/">PMC free article</a>]</span> [<a href="/pubmed/17325738" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1593%2Fneo.06619" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Neoplasia&amp;title=Circulating+haptoglobin+is+an+independent+prognostic+factor+in+the+sera+of+patients+with+epithelial+ovarian+cancer&amp;author=C+Zhao&amp;author=L+Annamalai&amp;author=C+Guo&amp;author=N+Kothandaraman&amp;author=SC+Koh&amp;volume=9&amp;publication_year=2007&amp;pages=1-7&amp;pmid=17325738&amp;doi=10.1593/neo.06619&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B30"><span class="citation">Zelvyte I, Wallmark A, Piitulainen E, Westin U, Janciauskiene S. Increased plasma levels of serine proteinase inhibitors in lung cancer patients. <span><span class="ref-journal">Anticancer Res. </span>2004;<span class="ref-vol">24</span>:241\xe2\x80\x93247.</span> [<a href="/pubmed/15015603" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Anticancer+Res&amp;title=Increased+plasma+levels+of+serine+proteinase+inhibitors+in+lung+cancer+patients&amp;author=I+Zelvyte&amp;author=A+Wallmark&amp;author=E+Piitulainen&amp;author=U+Westin&amp;author=S+Janciauskiene&amp;volume=24&amp;publication_year=2004&amp;pages=241-247&amp;pmid=15015603&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B31"><span class="citation">Wozniak A, Mila-Kierzenkowska C, Schachtschabel DO, Wozniak B, Rozwodowska M, Drewa T, Drewa S, Sir J, Sir I, Maciak R, Krzyzynska-Malinowska E. Activity of cathepsin D and alpha(1)-antitrypsin in the blood serum of patients with mammary carcinoma. <span><span class="ref-journal">Exp Oncol. </span>2005;<span class="ref-vol">27</span>:233\xe2\x80\x93237.</span> [<a href="/pubmed/16244588" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Exp+Oncol&amp;title=Activity+of+cathepsin+D+and+alpha(1)-antitrypsin+in+the+blood+serum+of+patients+with+mammary+carcinoma&amp;author=A+Wozniak&amp;author=C+Mila-Kierzenkowska&amp;author=DO+Schachtschabel&amp;author=B+Wozniak&amp;author=M+Rozwodowska&amp;volume=27&amp;publication_year=2005&amp;pages=233-237&amp;pmid=16244588&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li><li id="B32"><span class="citation">Wo&#x0017a;niak B, Mila-Kierzenkowska C, Wo&#x0017a;niak A, Drewa G, Sopo&#x000f1;ska M, Drewa T, Krzyzy&#x000f1;ska-Malinowska E, Makarewicz R, Kowalski T, Szmytkowska K. The effect of combined therapy on activity of cathepsin D and alpha-1-antitrypsin in the blood serum of women with cervical cancer. <span><span class="ref-journal">Eur J Gynaecol Oncol. </span>2008;<span class="ref-vol">29</span>:617\xe2\x80\x93619.</span> [<a href="/pubmed/19115690" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Gynaecol+Oncol&amp;title=The+effect+of+combined+therapy+on+activity+of+cathepsin+D+and+alpha-1-antitrypsin+in+the+blood+serum+of+women+with+cervical+cancer&amp;author=B+Wo&#x0017a;niak&amp;author=C+Mila-Kierzenkowska&amp;author=A+Wo&#x0017a;niak&amp;author=G+Drewa&amp;author=M+Sopo&#x000f1;ska&amp;volume=29&amp;publication_year=2008&amp;pages=617-619&amp;pmid=19115690&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2739531&amp;issue-id=176182&amp;journal-id=617&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></li></ul></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">Journal of Hematology &#x0026; Oncology</span> are provided here courtesy of <strong>BioMed Central</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2739531/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2739531/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2739531/pdf/1756-8722-2-37.pdf">PDF (728K)</a></li> | <li><a href="#" data-citationid="PMC2739531" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2739531%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2739531%2F&amp;text=Different%20altered%20stage%20correlative%20expression%20of%20high%20abundance%20acute-phase%20proteins%20in%20sera%20of%20patients%20with%20epithelial%20ovarian%20carcinoma"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2739531%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19709441" data-aiid="2739531" data-aid="2739531" data-iid="176182" data-domainid="617" data-domain="jhemonc" data-accid="PMC2739531" data-md5="f8548288e3494358b0b564e6c3aed74f"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:22:53-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B16BAE9A2F1A10000000009090909&amp;ncbi_session=8A1B16BAE9A485C1_2313SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2739531%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=jhemonc&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2739531/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B16BAE9A485C1_2313SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'